National Lymphoma Expert to Serve as Medical
Director and Deputy Director
for Clinical and Translational
FOR IMMEDIATE RELEASE
Date: March 21,
Contact: Rob Brogna
WORCESTER - Andrew Evens, DO, MSc, has been named deputy director for
clinical and translational research and medical director of the Clinical
Research Office within the UMass
Memorial Health Care Cancer Center of Excellence. He has also been named
associate professor of medicine and will lead the Lymphoma Program at University of Massachusetts Medical
A national expert in the prognosis and treatment of non-Hodgkin's lymphoma
and Hodgkin's disease/lymphoma, Dr. Evens joins UMass Memorial from the
Northwestern University Feinberg School of Medicine in Chicago, where he had
been since 2003. His responsibilities in this new role include leading the
clinical and translational research efforts from the laboratories in the Medical
School to the bedside in the Cancer Center of Excellence.
"We are excited to welcome a clinical cancer investigator of the stature of
Dr. Andy Evens," said Michael
Blute, MD, director of the UMass Memorial Cancer Center of Excellence. "An
internationally recognized leader in lymphoma clinical trials, Dr. Evens will
lead the Clinical Research Office in the Cancer Center of Excellence. This
important role will be responsible for all regulatory, compliance, safety and
quality issues related to human subject cancer research.
Board certified in internal medicine, hematology and medical oncology, Dr.
Evens attended Chicago College of Osteopathic Medicine and completed his
residency and chief residency at Lutheran General Hospital and a
hematology/oncology fellowship at Northwestern University Feinberg School of
Medicine. Over the past 10 years, Dr. Evens has been principal investigator for
a large number of hematology/oncology clinical trials and has published numerous
articles with a particular emphasis on new treatments in lymphoma.